A Brett Hauber
Affiliation: RTI International
- Estimating importance weights for the IWQOL-Lite using conjoint analysisA Brett Hauber
Health Preference Assessment, RTI Health Solutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
Qual Life Res 19:701-9. 2010..Our objective was to estimate preference-based weights for the IWQOL-Lite that reflect the relative importance overweight and obese people place on the domains included in the instrument...
- Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and GermanyA Brett Hauber
RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC, 27709 2194, USA
Qual Life Res 23:1813-21. 2014..To estimate the relative importance that Alzheimer's disease (AD) caregivers in the United States and Germany place on preserving patients' ability to perform activities of daily living...
- Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)A Brett Hauber
RTI Health Solutions, Research Triangle Park, NC, USA
Patient Prefer Adherence 5:307-14. 2011..To quantify gastrointestinal stromal tumor (GIST) patients' preferences for reducing treatment toxicities and the likely effect of toxicities on patients' stated adherence...
- Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literatureA Brett Hauber
RTI Health Solutions, 200 Park Office Drive, Research Triangle Park, NC 27709, USA
Appl Health Econ Health Policy 11:319-29. 2013....
- A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritisA B Hauber
Health Preference Assessment, RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
Osteoarthritis Cartilage 21:289-97. 2013..To assess patient preferences for treatment-related benefits and risks associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis (OA)...
- Patient preferences and assessment of likely adherence to hepatitis C virus treatmentA Brett Hauber
RTI International, RTP, Research Triangle Park, NC 27709 2194, USA
J Viral Hepat 18:619-27. 2011..Sustained viral response is the most important treatment attribute to patients but treatment side effects might affect treatment adherence...
- Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapiesA Brett Hauber
Health Preference Assessment, RTI International, Research Triangle Park, NC 27709, USA
Ann Pharmacother 44:479-88. 2010..The long-term management of many patients with chronic ITP is unsatisfactory, largely due to the variable efficacy and risks of severe adverse effects associated with current treatment options...
- Healthy-days time equivalents for outcomes of acute rotavirus infectionsA Brett Hauber
RTI International, RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
Vaccine 29:8086-93. 2011....
- Healthy-years equivalent: wounded but not yet deadA Brett Hauber
RTI Health Solutions, 200 Park Offices, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
Expert Rev Pharmacoecon Outcomes Res 9:265-9. 2009..This article provides a brief review of empirical applications of the HYE and identifies recent advances in empirical estimation that may breathe new life into a valiant, but wounded, measure...
- Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medicationsA Brett Hauber
RTI International, Research Triangle Park, North Carolina 27709 2194, USA
Allergy Asthma Proc 30:139-47. 2009....
- Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatmentsA Brett Hauber
RTI Health Solutions, RTI International, 200 Park Offices Drive, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
AIDS Patient Care STDS 23:29-34. 2009..Subjects were willing to accept increased risks of AEs in exchange for lower risk of virologic failure...
- Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber
RTI International, RTI HealthSolutions, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
Alzheimer Dis Assoc Disord 23:23-32. 2009..These results are consistent with other studies indicating that individuals view AD as a serious, life threatening illness that imposes heavy burdens on both patients and caregivers...
- Risking health to avoid injections: preferences of Canadians with type 2 diabetesA Brett Hauber
RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina, USA
Diabetes Care 28:2243-5. 2005
- The value to patients of reducing lesion severity in plaque psoriasisA Brett Hauber
RTI International, RTI Health Solutions, Research Triangle Park, NC, USA
J Dermatolog Treat 22:266-75. 2011..80 out-of-pocket per month to eliminate moderate lesions covering 4% BSA on the face. Individuals with plaque psoriasis are willing to pay substantial amounts to reduce lesion severity and percentage of BSA covered by lesions...
- Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and ItalyAteesha Farah Mohamed
RTI Health Solutions, Research Triangle Park, North Carolina 27709 2194, USA
Eur J Gastroenterol Hepatol 24:419-26. 2012..To quantify physicians' preferences among possible outcomes associated with chronic hepatitis B treatments and to determine which outcomes are most important to physicians in making treatment decisions...
- Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomesF Reed Johnson
RTI International, Research Triangle Park, NC 27709 2194, USA
Value Health 13:418-23. 2010..A scientifically valid method for assessing patients' benefit-risk trade-off preferences is needed to compare risks and benefits in a common metric...
- Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptomsF Reed Johnson
RTI Health Solutions, RTP, NC 27709 2194, USA
Value Health 12:146-52. 2009....
- Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysisGeorge Van Houtven
Research Triangle Institute, SSES Environmental, Technology, and Energy Economics, Research Triangle Park, NC, USA
Med Decis Making 31:469-80. 2011..6% to 7.1%. Our results provide further the evidence that quantitative benefit-risk analysis used to evaluate medical interventions should account explicitly for the nonlinear probability weighting of preferences...
- How do physicians weigh benefits and risks associated with treatments in patients with osteoarthritis in the United Kingdom?Nigel K Arden
Health Preference Assessment, RTI Health Solutions, Research Triangle Park, North Carolina, USA
J Rheumatol 39:1056-63. 2012..To quantify the relative importance that UK physicians attach to the benefits and risks of current drugs when making treatment decisions for patients with osteoarthritis (OA)...
- Factors that affect adherence to bipolar disorder treatments: a stated-preference approachF Reed Johnson
RTI Health Solutions, North Carolina, USA
Med Care 45:545-52. 2007..Medication nonadherence is high among patients with bipolar disorder, and may lead to poor clinical outcomes, decreased quality of life, and increased resource utilization...
- Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approachF Reed Johnson
RTI Health Solutions, Research Triangle Institute, Research Triangle Park, NC 27709 2194, USA
Qual Life Res 15:285-98. 2006....
- Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinomaAteesha F Mohamed
RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
Pharmacoeconomics 29:977-88. 2011..Angiogenesis inhibitor agents have been shown to be effective in increasing progression-free survival (PFS) in patients with renal cell carcinoma (RCC); however, these treatments have different toxicity profiles...
- Who pays attention in stated-choice surveys?Semra Ozdemir
Department of Environmental Sciences and Engineering, University of North Caroline at Chapel Hills, NC 27709 2194, USA
Health Econ 19:111-8. 2010..Understanding the characteristics of subjects who are inattentive to the choice task may help in designing and pre-testing instruments that work effectively for a wider range of subjects...
- Patient preferences for treatments to delay bone metastasesA Brett Hauber
RTI Health Solutions, Research Triangle Park, North Carolina
Prostate 74:1488-97. 2014..The study also assessed the value patients place on avoiding metastasis-induced bone complications versus increased survival...
- Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspectiveA Brett Hauber
RTI Health Solutions, Research Triangle Park, North Carolina, USA
J Opioid Manag 7:287-96. 2011..The authors aimed to estimate the economic value of this product relative to other widely used oral opioids, including sustained-release morphine, extended-release (ER) oxycodone, and twice-daily (bid) hydromorphone...
- Patient preferences and linear scoring rules for patient-reported outcomesAteesha F Mohamed
Research Triangle Institute, Research Triangle Park, North Carolina, USA
Patient 3:217-27. 2010....
- Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatmentsChristine Poulos
RTI Solutions, Research Triangle Park, North Carolina
Arthritis Care Res (Hoboken) 66:1008-15. 2014..This study aimed to quantify the rate at which RA patients are willing to trade off between the time required to administer treatment (duration) and treatment frequency...
- The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudyEdward P Havranek
Division of Cardiology, Denver Health Medical Center, University of Colorado Health Sciences Center, Denver, Colorado 80204 4507, USA
J Card Fail 10:339-43. 2004..Measuring utilities for all subjects in a large-scale randomized trial, however, would be prohibitively cumbersome. We therefore sought to estimate utilities for all subjects from results obtained in a subset of patients...